Welcome to your
VYVGART journey!


As you get started, know you aren’t alone on the treatment journey. The Patient Support Program, My VYVGART Path, is here for you. Learn how the My VYVGART Path team provides personalized support at every step.

VYVGART downloadable resources


Whether you're an adult living with anti-acetylcholine receptor (AChR) antibody positive generalized myasthenia gravis (gMG) or you’re a caregiver, My VYVGART Path has helpful resources to help you feel supported throughout the treatment journey.

My VYVGART Path brochure

See how the My VYVGART Path Patient Support Program can empower you on your VYVGART treatment journey.

My VYVGART Path enrollment form

Fill out this form once you have been prescribed VYVGART to enroll yourself in My VYVGART Path.

VYVGART brochure

This brochure contains important information about VYVGART for intravenous (IV) infusion and VYVGART Hytrulo for subcutaneous injection. Learn about how they work, study results and safety data, dosing, and much more!

IV=intravenous

VYVGART Co-pay Program brochure

See if you could be eligible to pay as little as $0 for your co-pay through the VYVGART Co-pay Program.*

*Eligible commercially insured patients may pay as little as $0 for VYVGART and may receive a maximum benefit of $25,000 per calendar year for their eligible out-of-pocket costs for the drug and drug administration. Persons residing in MA and RI are not eligible for financial assistance related to administration costs. Please see full Terms and Conditions.

What’s Next guide

The “What’s Next?” patient guide outlines what you can expect as you begin your journey with VYVGART, from navigating insurance to starting your first treatment cycle.

Insurance and coverage guide

Learn about the insurance process and see how the My VYVGART Path team may assist you in accessing VYVGART.

Dosing guide

Information about dosing with VYVGART and treatment cycles.

In-office subcutaneous injection guide

Information about dosing and how to prepare for your VYVGART Hytrulo subcutaneous injection.

Infusion guide

Information on the VYVGART for IV infusion process: before, during, and after. 

MG-ADL assessment tool

Use this tool to track your symptoms regularly, as it may help you and your neurologist determine your next treatment cycle.

MG-ADL=Myasthenia Gravis Activities of Daily Living

Personal Ability Goal setting worksheet

This tool can help you set a gMG treatment goal and share it with your doctor.

Understanding your gMG symptoms: vision and eye symptoms

In these 4 educational guides, learn about the different types of symptoms you may experience with gMG.

Understanding your gMG symptoms: face, mouth, and throat symptoms

In these 4 educational guides, learn about the different types of symptoms you may experience with gMG.

Understanding your gMG symptoms: breathing problems

In these 4 educational guides, learn about the different types of symptoms you may experience with gMG.

Understanding your gMG symptoms: limb weakness

In these 4 educational guides, learn about the different types of symptoms you may experience with gMG.

Doctor discussion guide

The VYVGART Doctor Discussion Guide can be used to help you discuss with your neurologist current anti-AChR antibody positive gMG symptoms you have and how they impact your daily abilities.

AChR=acetylcholine receptor

Conversation guide for family, friends, and loved ones

This guide will help you facilitate productive conversations with family and friends, where you can define and ask for the support you might need.

Conversation tips for employers

These tips provide some considerations for talking to your employer and coworkers about gMG and treatment.

Patient emergency contact card

Use this card to share treatment information and key contacts in the case of an emergency.

gMG=generalized myasthenia gravis

Image of an NCM

Still have questions?

Call My VYVGART Path for help at 1-833-MY-PATH-1 (1-833-697-2841).

What’s next? Tracking symptoms to help inform a treatment plan

After starting treatment, you will work with your doctor to find personalized breaks between cycles based on your symptoms and side effects. Learn more about dosing and what to expect during this step in the journey.

My Vyvgart Path

Looking for a different way to track symptoms?


For personalized support WHEREVER YOU GO, download the Medisafe app

  • Track symptoms
  • Set appointment reminders
  • Explore education and resources

QR Code

Scan to download from your device’s app store

DOWNLOAD THE APP

Google Play logo

Apple Store logo

What makes a good discussion between a doctor and patient?

Watch the video to hear how Steve—a real patient on VYVGART for intravenous (IV) infusion—discusses symptom tracking, treatment goals, and more with his neurologist.

Get the latest VYVGART updates

Sign up to get the latest information about VYVGART sent straight to your inbox.

Footer logos
VYVGART®-Combined-RGB_KO-VERTICAL

Still have questions? Call 1-833-VYVGART (1-833-898-4278) to speak with an educator about gMG, how VYVGART works, study data, cost and coverage, and more.

Do not use VYVGART if you have a serious allergy to efgartigimod alfa or any of the other ingredients in VYVGART. Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART and VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

VYVGART and VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART and VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Allergic Reactions (hypersensitivity reactions). VYVGART and VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
  • Infusion-Related Reactions. VYVGART and VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.

Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART or VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.

Before taking VYVGART or VYVGART HYTRULO, tell your doctor if you:

  • take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
  • have received or are scheduled to receive a vaccine (immunization), or
  • have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.

What are the common side effects of VYVGART and VYVGART HYTRULO?

The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART and VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines, each used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and the full Prescribing Information for VYVGART HYTRULO, and talk to your doctor.

Do not use VYVGART if you have a serious allergy to efgartigimod alfa or any of the other ingredients in VYVGART. Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART and VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

VYVGART and VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART and VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Allergic Reactions (hypersensitivity reactions). VYVGART and VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
  • Infusion-Related Reactions. VYVGART and VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.

Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART or VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.

Before taking VYVGART or VYVGART HYTRULO, tell your doctor if you:

  • take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
  • have received or are scheduled to receive a vaccine (immunization), or
  • have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.

What are the common side effects of VYVGART and VYVGART HYTRULO?

The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART and VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines, each used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and the full Prescribing Information for VYVGART HYTRULO, and talk to your doctor.